Dr. Rho is currently a Professor of Neurosciences, Pediatrics and Pharmacology at the University of California, San Diego, and Division Chief of Pediatric Neurology at the Rady Children’s Hospital San Diego. He received an undergraduate degree in molecular biophysics and biochemistry from Yale University, and a M.D. from the University of Cincinnati (Ohio). Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital, the University of California at Irvine, the Barrow Neurological Institute (Phoenix), University of Arizona and Arizona State University, and most recently, the University of Calgary and the Alberta Children’s Hospital (Alberta, Canada). Dr. Rho's main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet, and the neuropharmacology of anti-seizure medications. His research activities have been sponsored by the U.S. National Institutes of Health (NIH), the Canadian Institutes for Health Research (CIHR), as well as a variety of intramural and extramural public and private sector sources. Dr. Rho has served on the editorial boards of Epilepsia, Epilepsia Open, Seizure and Epilepsy Currents, and has been a regular reviewer for research grants submitted to the NIH and CIHR. In addition to an extensive list of publications in basic science and pediatric neurology peer-reviewed journals, Dr. Rho has written numerous book chapters, edited several books, and is a popular national and international guest lecturer.